We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Africa Centres for Disease Control and Prevention reports continuing occurrence of Ebola virus disease in the outbreak that was announced on 30 January 2025.
As of 10 February 2025 there have been 9 cases incluiding 1 death in the Kampala area.
Ebola virus disease (EVD) is a type of viral haemorrhagic fever (VHF). It is spread through contact with the blood, body fluids or organs of a person or animal with the infection.
Currently, there is no licensed vaccine available for UK travellers to prevent EVD.
The risk to travellers becoming infected or developing EVD is extremely low.
The risk to travellers becoming infected or developing EVD is extremely low. The risk may be higher for medical personnel travelling to work in an outbreak region.
All travellers can minimise their risk of becoming infected or developing EVD by:
In addition, travellers should be reminded of general preventative travel health measures to avoid becoming unwell, including:
People who are travelling to the affected areas to work in response to the outbreak should seek risk assessment advice and training from their employer / organisation before travel. They must also be registered with the UKHSA Ebola and Marburg: returning workers scheme (RWS) before travel.
Travellers should be made aware what they need to do if they develop a fever, with or without additional symptoms (such as headache, myalgia, weakness, abdominal pain, sore throat, vomiting, diarrhoea, unexplained bleeding / bruising), and have:
In this instance, travellers should seek rapid medical attention by calling NHS 24 (Scotland) or NHS 111 (rest of UK), or contacting their GP practice by telephonefor advice.
Although it is very unlikely the traveller will have EVD, they should be advised to mention:
For further information, see the TRAVAX Viral Haemorrhagic Fever page.